
G-Iron200 mg/5 m
Gonoshasthaya Pharmaceuticals Limited

Ascoferon does not treat anemia that is not due to iron deficiency (e.g., anemia of chronic disease, hemolytic anemia, or vitamin B12/folate deficiency anemia) and should not be used for these without confirmed iron deficiency.
Each tablet/capsule of Ferrous Sulfate typically contains Ferrous Sulfate equivalent to a specified amount of elemental iron (commonly 200 mg Ferrous Sulfate providing approximately 60-65 mg elemental iron, or dried/exsiccated Ferrous Sulfate 150-200 mg providing a similar amount of elemental iron). Oral liquid formulations (elixir/drops) contain Ferrous Sulfate in a lower per-mL concentration for pediatric or dose-titrated use. Exact strength varies by manufacturer and dosage form; refer to the specific product label for the elemental iron content.
Ascoferon is an iron salt used as an oral iron replacement product. It supplies ferrous (Fe2+) iron, the form ofiron that is most readily absorbed from the gastrointestinal tract, to replenish body iron stores and supporthemoglobin synthesis. Ascoferon is one of the oldest and most widely used oral iron preparations and is considered afirst-line, cost-effective treatment for iron-deficiency anemia.
Ascoferon is available in immediate-release tablets, enteric-coated/extended-release tablets, capsules, and oralliquid (elixir/drops) formulations for adults and children.
Ascoferon belongs to the therapeutic class of hematinics / antianemic preparations, specifically oral iron (ferrous) salts used to treat and prevent iron-deficiency anemia.
Ferrous Sulfate dissociates in the gastrointestinal tract to release ferrous (Fe2+) iron, which is the form activelyabsorbed by enterocytes, predominantly in the duodenum and proximal jejunum, via the divalent metal transporter(DMT1). Absorbed iron is either stored intracellularly as ferritin or transported into the bloodstream viaferroportin, where it binds to transferrin for delivery to the bone marrow. There, iron is incorporated intoprotoporphyrin IX to form heme, an essential component of hemoglobin, enabling normal erythropoiesis and oxygentransport. Iron is also a cofactor for myoglobin and several enzymes involved in cellular respiration and energymetabolism.
Absorption of iron from Ferrous Sulfate is enhanced by an acidic gastric environment and by vitamin C, and is reduced byfood, antacids, calcium, and certain other agents (see Interactions). Absorption is inversely related to bodyiron stores - it increases when iron stores are depleted and decreases as they are replenished.
| Indication | Typical Adult Dose |
|---|---|
| Treatment of iron-deficiency anemia | Ascoferon providing 100-200 mg elemental iron per day, in 1-3 divided doses (e.g., Ascoferon 325 mg tablet, providing about 65 mg elemental iron, once to three times daily) |
| Prevention of iron deficiency (e.g., pregnancy) | Ascoferon providing 30-60 mg elemental iron once daily |
Some clinicians and recent evidence favor alternate-day dosing of Ascoferon (rather than multiple daily doses) toimprove fractional iron absorption and reduce gastrointestinal side effects; the prescribing physician'sinstructions should be followed.
| Indication | Typical Pediatric Dose |
|---|---|
| Treatment of iron-deficiency anemia | Ascoferon providing 3-6 mg/kg/day elemental iron, in 1-3 divided doses (physician/weight-guided) |
| Prevention of iron deficiency (infants/children) | Ascoferon providing 1-2 mg/kg/day elemental iron, once daily |
No well-established dose adjustment of Ascoferon is required for renal or hepatic impairment, as oral iron is notsignificantly cleared by the kidney or metabolized by the liver; however, patients with hepatic disease shoulduse Ascoferon under medical supervision because of a theoretical risk of iron accumulation.
Ascoferon should ideally be taken on an empty stomach (1 hour before or 2 hours after meals) with a full glass ofwater for optimal absorption. It may be taken with a small amount of food if stomach upset occurs, though thislowers absorption. Avoid taking Ascoferon together with antacids, calcium, dairy, tea, or coffee; separate these by atleast 2 hours. Do not lie down for 10 minutes after taking liquid or tablet forms of Ascoferon to reduce the risk ofthroat irritation.
| Interacting Agent | Effect / Mechanism | Recommendation |
|---|---|---|
| Antacids, calcium supplements, dairy products | Reduce absorption of iron from Ascoferon by raising gastric pH and/or forming insoluble complexes | Separate administration by at least 2 hours |
| Tea, coffee | Tannins bind iron and reduce absorption of Ascoferon | Avoid taking together; separate by at least 2 hours |
| Tetracyclines (e.g., doxycycline) | Ascoferon chelates tetracyclines, reducing absorption of both the antibiotic and the iron | Separate administration by at least 2-3 hours |
| Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) | Ascoferon chelates fluoroquinolones, markedly reducing antibiotic absorption and efficacy | Separate administration by at least 2 hours (fluoroquinolone before or well after Ascoferon) |
| Levothyroxine | Ascoferon reduces absorption of levothyroxine, which may reduce thyroid hormone efficacy | Separate administration by at least 4 hours |
| Levodopa, methyldopa | Ascoferon may reduce absorption and efficacy of these agents via chelation | Separate administration by at least 2 hours; monitor clinical response |
| Proton pump inhibitors / H2-blockers | Reduced gastric acidity decreases absorption of iron from Ascoferon | Monitor response to iron therapy; dose adjustment or alternative iron formulation may be considered |
Ferrous Sulfate is contraindicated in:
Iron overdose from Ascoferon can cause serious, potentially fatal toxicity, especially in young children - seeOverdose section. Any signs of severe abdominal pain, vomiting blood, black tarry stools with instability, orlethargy after excessive intake require immediate emergency care.
Pregnancy: Ascoferon is commonly recommended during pregnancy at appropriate doses to prevent andtreat iron-deficiency anemia, which is common in pregnancy and associated with adverse maternal and fetaloutcomes if untreated. As with any medication in pregnancy, Ascoferon should be used only as advised by a physician,at the dose and duration recommended, since excessive iron intake beyond physiological requirement is notadvised; do not exceed the prescribed dose. Consult a physician before starting or adjusting Ascoferon duringpregnancy.
Lactation: Ascoferon is generally considered compatible with breastfeeding, as iron is notexcreted into breast milk in clinically significant amounts affecting the infant. Ascoferon may be used bybreastfeeding mothers for treatment or prevention of iron-deficiency anemia under medical guidance.
Overdose of Ascoferon is a medical emergency, particularly in children, and can be fatal. Early symptoms(within the first hours) may include nausea, vomiting (sometimes bloody), abdominal pain, and diarrhea (which maybe bloody); these may appear to improve temporarily before a more dangerous phase develops over the next6-24+ hours, including metabolic acidosis, lethargy, low blood pressure, seizures, liver damage, andcardiovascular collapse.
If overdose of Ascoferon is suspected - even if the child or person initially appears well or symptomsseem mild - seek immediate emergency medical attention or contact a poison control center right away.Do not wait for symptoms to worsen. Take the container of Ascoferon with you to the hospital. Treatment issupportive and may include specific iron-chelation therapy administered by medical professionals; do not attempthome treatment.
Store at room temperature (below 30°C), away from light and moisture, in a tightly closed, child-resistant container. Keep out of reach and sight of children at all times.
Ascoferon is used in infants and children for treatment and prevention of iron-deficiency anemia at weight-baseddoses (see Dosage and Administration). Because accidental overdose of Ascoferon is a leading cause of fatal pediatricpoisoning, extra caution with storage and dosing accuracy is essential in this population.
Ascoferon may be used in elderly patients at standard adult doses; this population may be more prone toconstipation and gastrointestinal intolerance, and underlying causes of iron deficiency (e.g., occultgastrointestinal blood loss, malignancy) should be investigated rather than assuming dietary deficiency alone.
No specific dose adjustment of Ascoferon is established for renal impairment; iron status should be monitored,particularly in patients with chronic kidney disease who may have altered iron metabolism.
Use Ascoferon with caution in significant hepatic impairment due to a theoretical risk of iron accumulation;monitor iron parameters during prolonged use.
Ascoferon is typically continued for 3 to 6 months after hemoglobin has returned to normal, in order to replenishdepleted iron stores (ferritin). Total duration varies with the severity of deficiency and ongoing losses.Hemoglobin response is usually assessed after 2-4 weeks of therapy; if there is no adequate response, thephysician should reassess the diagnosis, adherence, and dosing of Ascoferon rather than extending treatmentindefinitely without review.
Hematinic; oral iron (ferrous) salt; antianemic preparation.
Ferrous Sulfate releases ferrous (Fe2+) iron, which is absorbed in the duodenum and proximal jejunum and transported viatransferrin to the bone marrow, where it is incorporated into hemoglobin to support normal red blood cellproduction and oxygen-carrying capacity. Supplementation with Ferrous Sulfate corrects iron deficiency by replenishing bothcirculating iron available for erythropoiesis and stored iron (ferritin) reserves.
Ascoferon is used in pediatric patients, including infants, for the treatment and prevention of iron-deficiencyanemia, dosed by body weight (see Dosage and Administration). Safety and appropriate dosing should always beguided by a pediatrician, particularly in infants and premature or low-birth-weight babies. Because Ascoferon inoverdose is a well-documented and potentially fatal cause of accidental childhood poisoning, parents andcaregivers must store Ascoferon in child-resistant packaging, well out of reach and sight of children, and must neverallow a child to self-administer it.
Q: What is Ascoferon 200 mg/5 ml Syrup used for?
A: Ascoferon 200 mg/5 ml Syrup is used to treat and prevent iron-deficiency anemia, a condition in which the body does not have enough iron to make adequate hemoglobin and red blood cells. It is commonly prescribed for people with confirmed low iron levels, including pregnant women, infants, and people with chronic blood loss.
Q: How should I take Ascoferon 200 mg/5 ml Syrup for the best absorption?
A: For best absorption, take Ascoferon 200 mg/5 ml Syrup on an empty stomach, about 1 hour before or 2 hours after meals, with a full glass of water. If it causes stomach upset, you may take Ascoferon 200 mg/5 ml Syrup with a small amount of food, but this will reduce how much iron your body absorbs. Avoid taking it with tea, coffee, calcium, dairy products, or antacids - separate these by at least 2 hours.
Q: Is it normal for my stools to turn dark or black while taking Ascoferon 200 mg/5 ml Syrup?
A: Yes, dark or black stools are a common and harmless side effect of Ascoferon 200 mg/5 ml Syrup caused by unabsorbed iron passing through the gut. However, if you notice tarry, foul-smelling black stools together with dizziness, weakness, or abdominal pain, contact your doctor promptly, as these could indicate gastrointestinal bleeding rather than the expected effect of Ascoferon 200 mg/5 ml Syrup.
Q: Can Ascoferon 200 mg/5 ml Syrup be dangerous for children?
A: Yes. Accidental overdose of Ascoferon 200 mg/5 ml Syrup is a well-documented and potentially fatal cause of poisoning in young children, even from a relatively small number of tablets. Always keep Ascoferon 200 mg/5 ml Syrup in its original child-resistant container, stored well out of the sight and reach of children, and never refer to it as candy. If a child may have swallowed Ascoferon 200 mg/5 ml Syrup, seek emergency medical attention immediately, even if the child seems fine at first.
Q: Can I take Ascoferon 200 mg/5 ml Syrup with my other medications?
A: Ascoferon 200 mg/5 ml Syrup can reduce the absorption of certain drugs, including tetracycline antibiotics, fluoroquinolone antibiotics (such as ciprofloxacin), and levothyroxine, and its own absorption is reduced by antacids and calcium supplements. Generally, these should be separated from Ascoferon 200 mg/5 ml Syrup by at least 2 hours (4 hours for levothyroxine). Tell your doctor or pharmacist about all medications you take before starting Ascoferon 200 mg/5 ml Syrup.
Q: Is Ascoferon 200 mg/5 ml Syrup safe during pregnancy and breastfeeding?
A: Ascoferon 200 mg/5 ml Syrup is commonly recommended during pregnancy to treat and prevent iron-deficiency anemia, and is generally considered compatible with breastfeeding. However, it should be used only at the dose and duration advised by your physician, since your iron needs should be individually assessed - consult your doctor before starting or continuing Ascoferon 200 mg/5 ml Syrup during pregnancy or lactation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.